Vestibular Perception Gates Autonomic Responses to Sinusoidal Galvanic Vestibular Stimulation
GVS-HRV
Effects of Galvanic Vestibular Stimulation on Heart Rate Variability
3 other identifiers
interventional
56
1 country
2
Brief Summary
Brief Summary This randomized, double-blind, sham-controlled clinical trial is designed to investigate whether repeated sinusoidal galvanic vestibular stimulation (GVS) influences cardiac autonomic regulation in healthy adults during their routine occupational activities, and to determine whether these effects depend on subjective vestibular perception (dizziness) experienced during stimulation. The main questions it aims to answer are: Does repeated sinusoidal GVS alter heart rate variability (HRV) in healthy adults during their normal work activities? Do autonomic responses to GVS depend on the subjective intensity of dizziness experienced during stimulation? Does repeated GVS affect psycho-emotional well-being, including depressive and anxiety symptoms? Researchers will compare active GVS to sham stimulation to see if active stimulation produces measurable changes in cardiac autonomic regulation and whether these changes differ between participants reporting stronger versus minimal dizziness. Participants will undergo baseline assessment, complete four consecutive daily sessions of active or sham GVS, and undergo post-intervention assessment. Autonomic responses will be assessed using multiple HRV indices.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy-volunteers
Started Nov 2021
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 30, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
May 13, 2022
CompletedFirst Submitted
Initial submission to the registry
July 9, 2026
CompletedFirst Posted
Study publicly available on registry
July 20, 2026
CompletedJuly 20, 2026
July 1, 2026
5 months
July 9, 2026
July 15, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Heart Rate Variability (HRV) Indices from Baseline to Post-Course and During Acute Stimulation
HRV will be assessed using complementary indices derived from continuous ambulatory ECG recordings (Polar H10) across multiple temporal scales: (1) course-level: baseline vs. post-course comparison; (2) acute: pre-stimulation, during stimulation, and post-stimulation epochs; (3) macro-scale: one-hour pre-stimulation vs. one-hour post-stimulation windows. Indices include time-domain (SDNN, mean RR intervals), frequency-domain (HFnu), nonlinear (SD1, SD2, SD2/SD1 ratio, DFA α1), and geometric (Baevsky Stress Index) measures.
• Baseline (Day 1) • Days 2-5 (pre-stimulation, during 6-minute stimulation, immediately post-stimulation, and 1 hour post-stimulation) • Day 6 (post-course assessment)
Secondary Outcomes (5)
Autonomic Responses by Vestibular Perception Subgroups (High vs Low/No Dizziness)
• Baseline (Day 1) • Days 2-5 (pre-stimulation, during 6-minute stimulation, immediately post-stimulation, and 1 hour post-stimulation) • Day 6 (post-course assessment)
Stimulation-Related Sensations and Tolerability
• Days 2-5 (immediately after each stimulation session)
Changes in Psycho-Emotional Well-Being (Depressive Symptoms, Anxiety, and Affect)
• Baseline (Day 1) • Day 6 (post-course assessment)
Blinding Integrity Assessment
• Day 5 (immediately after the fourth stimulation session)
Change in Positive and Negative Affect as Measured by the PANAS
• Days 2-5 (morning, pre-stimulation, post-stimulation, and end of workday)
Study Arms (2)
Active GVS
EXPERIMENTALParticipants receive active sinusoidal galvanic vestibular stimulation (GVS) using the BrainPatch device. Stimulation parameters: 0.1 Hz sinusoidal waveform, peak current 0.62 mA, delivered for 6 minutes through bilateral electrodes placed over the mastoid processes. Participants remain seated with eyes closed while listening to relaxing meditative music. Stimulation is administered once daily for four consecutive days.
Sham GVS
SHAM COMPARATORAn identical acoustic environment was created in the Sham group. To ensure effective blinding, participants in the Sham group received only one 10-second stimulation cycle at the beginning of the 6-minute session.
Interventions
Sinusoidal galvanic vestibular stimulation delivered via bilateral mastoid electrodes using the portable BrainPatch device. Stimulation parameters: 0.1 Hz sinusoidal waveform, peak current 0.62 mA, administered for 6 minutes per session with participants seated, eyes closed, and listening to relaxing meditative music.
Eligibility Criteria
You may qualify if:
- Аge between 18 and 49 years
- Absence of dermatological conditions (e.g., eczema, psoriasis) or open wounds in the electrode placement area (mastoid region)
- No metallic or electronic implants (e.g., pacemakers, cochlear implants)
- No history of neurological, psychiatric, or cardiovascular disorders
- Not currently pregnant
- Employment or activities not involving the operation of vehicles or hazardous machinery
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Al-Farabi Kazakh National Universitylead
- Research and Production Center "Comprehensive Equipment"collaborator
- BrainPatchcollaborator
Study Sites (2)
JSC "Kazakhtelecom"
Almaty, 050004, Kazakhstan
Al-Farabi Kazakh National University
Almaty, 050040, Kazakhstan
Related Publications (11)
Kollmansperger S, Decker J, Berkes S, Jahn K, Wuehr M. A mobile electrical stimulator for therapeutic modulation of the vestibular system - design, safety, and functionality. Front Neurol. 2024 Nov 13;15:1502204. doi: 10.3389/fneur.2024.1502204. eCollection 2024.
PMID: 39606706BACKGROUNDPliego A, Vega R, Gomez R, Reyes-Lagos JJ, Soto E. A transient decrease in heart rate with unilateral and bilateral galvanic vestibular stimulation in healthy humans. Eur J Neurosci. 2021 Jul;54(2):4670-4681. doi: 10.1111/ejn.15338. Epub 2021 Jun 22.
PMID: 34076918BACKGROUNDThayer JF, Lane RD. A model of neurovisceral integration in emotion regulation and dysregulation. J Affect Disord. 2000 Dec;61(3):201-16. doi: 10.1016/s0165-0327(00)00338-4.
PMID: 11163422BACKGROUNDMatsugi A, Nagino K, Shiozaki T, Okada Y, Mori N, Nakamura J, Douchi S, Oku K, Nagano K, Tamaru Y. No Impact of Stochastic Galvanic Vestibular Stimulation on Arterial Pressure and Heart Rate Variability in the Elderly Population. Front Hum Neurosci. 2021 Feb 17;15:646127. doi: 10.3389/fnhum.2021.646127. eCollection 2021.
PMID: 33679355BACKGROUNDYamamoto Y, Struzik ZR, Soma R, Ohashi K, Kwak S. Noisy vestibular stimulation improves autonomic and motor responsiveness in central neurodegenerative disorders. Ann Neurol. 2005 Aug;58(2):175-81. doi: 10.1002/ana.20574.
PMID: 16049932BACKGROUNDCraig AD. How do you feel--now? The anterior insula and human awareness. Nat Rev Neurosci. 2009 Jan;10(1):59-70. doi: 10.1038/nrn2555.
PMID: 19096369BACKGROUNDShaffer F, Ginsberg JP. An Overview of Heart Rate Variability Metrics and Norms. Front Public Health. 2017 Sep 28;5:258. doi: 10.3389/fpubh.2017.00258. eCollection 2017.
PMID: 29034226BACKGROUNDYates BJ, Bolton PS, Macefield VG. Vestibulo-sympathetic responses. Compr Physiol. 2014 Apr;4(2):851-87. doi: 10.1002/cphy.c130041.
PMID: 24715571BACKGROUNDMarchand S, Langlade A, Legois Q, Severac Cauquil A. A wide-ranging review of galvanic vestibular stimulation: from its genesis to basic science and clinical applications. Exp Brain Res. 2025 Apr 27;243(5):131. doi: 10.1007/s00221-025-07079-8.
PMID: 40289049BACKGROUNDDlugaiczyk J, Gensberger KD, Straka H. Galvanic vestibular stimulation: from basic concepts to clinical applications. J Neurophysiol. 2019 Jun 1;121(6):2237-2255. doi: 10.1152/jn.00035.2019. Epub 2019 Apr 17.
PMID: 30995162BACKGROUNDHeart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Eur Heart J. 1996 Mar;17(3):354-81. No abstract available.
PMID: 8737210BACKGROUND
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 9, 2026
First Posted
July 20, 2026
Study Start
November 30, 2021
Primary Completion
May 13, 2022
Study Completion
May 13, 2022
Last Updated
July 20, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- STUDY PROTOCOL, SAP, ICF
- Time Frame
- De-identified individual participant data and supporting documents will be available beginning 9 months following publication of the main results and ending 5 years after publication.
- Access Criteria
- Data and supporting documents will be made available upon reasonable request to the principal investigator. Requests will be reviewed to ensure appropriate use and compliance with ethical standards.
De-identified individual participant data that underlie the results reported in this article, including: Demographic and anthropometric data (age, sex, body mass index) Heart rate variability indices (time-domain: SDNN, mean RR intervals; frequency-domain: HFnu; nonlinear: SD1, SD2, SD2/SD1 ratio, DFA α1; geometric: Baevsky Stress Index) Psychometric questionnaire scores (PANAS, IDS-SR, GAD-7) Stimulation-related sensations ratings (dizziness, warmth, burning, itching) Data dictionaries defining all variables will be provided alongside the datasets.